J KEVIN BUCHI Insider Trading $IPXL Impax Laboratories, LLC
Get free email notifications about insider trading for J KEVIN BUCHI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of J KEVIN BUCHI. J KEVIN BUCHI is Chief Executive Officer in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and Director in IMPAX LABORATORIES INC ($IPXL) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in STEMLINE THERAPEUTICS INC ($STML) and Director in Alexza Pharmaceuticals Inc. ($ALXA) and President & CEO in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Amneal Pharmaceuticals, Inc. ($AMRX).
J KEVIN BUCHI in Impax Laboratories, LLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J KEVIN BUCHI: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 08 2018
$IPXL Market Capitalization: $952.26M
$IPXL Previous Close: $13.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of J KEVIN BUCHI in Impax Laboratories, LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXA, AMRX, BSTCE, DRNA, CRXX, IPXL, STML, TLOG, ZIOP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 08 2018 | IPXL | Impax Laboratories ... | BUCHI J KEVIN | Director | Option Exercise | D | 14.45 | 20,445 | 295,430 | 0 | |
| May 08 2018 | IPXL | Impax Laboratories ... | BUCHI J KEVIN | Director | Option Exercise | D | 16.40 | 7,931 | 130,068 | 0 | |
| May 08 2018 | IPXL | Impax Laboratories ... | BUCHI J KEVIN | Director | Sell | D | 0.00 | 3,281 | 0 | 0 | 3.3 K to 0 (-100.00 %) |
| May 08 2018 | IPXL | Impax Laboratories ... | BUCHI J KEVIN | Director | Sell | D | 0.00 | 8,020 | 0 | 0 | 8 K to 0 (-100.00 %) |
| May 17 2017 | IPXL | IMPAX LABORATORIES ... | BUCHI J KEVIN | Director | Option Exercise | A | 16.40 | 7,931 | 130,068 | 7,931 | |
| May 17 2017 | IPXL | IMPAX LABORATORIES ... | BUCHI J KEVIN | Director | Grant | A | 0.00 | 3,281 | 0 | 11,301 | 8 K to 11.3 K (+40.91 %) |
| Nov 28 2016 | IPXL | IMPAX LABORATORIES ... | BUCHI J KEVIN | Director | Option Exercise | A | 14.45 | 20,445 | 295,430 | 20,445 | |
| Nov 28 2016 | IPXL | IMPAX LABORATORIES ... | BUCHI J KEVIN | Director | Grant | A | 0.00 | 8,020 | 0 | 8,020 | 0 to 8 K |
Page: 1